DUBLIN--(BUSINESS WIRE)--The "Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instruments), Technique (Flow Cytometry, NGS, PCR, Mass Spectrometry, Microscopy), Application (Research, Medical Application), End User - Global Forecasts to 2025" report has been added to ResearchAndMarkets.com's offering.
The global single-cell analysis market is projected to reach USD 5.6 billion by 2025 from USD 2.1 billion in 2019, at a CAGR of 17.8% during the forecast period.
The growth in this market is attributed to technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and the increasing incidence and prevalence of chronic and infectious diseases. However, the high cost of single-cell analysis products is expected to restrain the growth of this market to a certain extent during the forecast period.
The academic & research laboratories segment accounted for the largest market share in 2018
On the basis of end-user, the single-cell analysis market is segmented into academic and research laboratories, biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, and cell banks and IVF centers. The academic and research laboratories segment accounted for the largest market share in 2018. Factors such as growth in funding for life science research and the increasing number of medical colleges and universities are driving the growth of this end-user segment.
Flow cytometry is the largest technique segment of the single-cell analysis market
Based on the technique, the single-cell analysis market is segmented into flow cytometry, NGS, PCR, microscopy, mass spectrometry, and other techniques. The flow cytometry segment accounted for the largest market share in 2018. The large share of this segment is attributed to the wide usage of flow cytometry in detecting and measuring the physical and chemical characteristics of a population of cells or particles.
North America will continue to dominate the single-cell analysis market in 2025
The single-cell analysis market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the single-cell analysis market. The large share of North America can be attributed to the increasing drug development activities in the pharmaceutical and biotechnology industries, rising prevalence of chronic and infectious diseases, and an increase in stem cell research activities.
- Technological Advancements in Single-cell Analysis Products
- Increasing Government Funding for Cell-Based Research
- Growing Biotechnology and Biopharmaceutical Industries
- Wide Applications of Single-cell Analysis in Cancer Research
- Growing Focus on Personalized Medicine
- Increasing Incidence and Prevalence of Chronic and Infectious Diseases
- High Cost of Single-cell Analysis Products
- High Growth Potential of Single-Cell Sequencing (SCS)
- Growth in Stem Cell Research
- Integration of Microfluidics in Single-cell Analysis
- Emerging Asian Markets
Survival of Small Players and New Entrants
- Becton, Dickinson and Company
- Danaher Corporation
- Merck Millipore
- QIAGEN N.V.
- Thermo Fisher Scientific, Inc.
- General Electric Company
- 10x Genomics
- Promega Corporation
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Fluidigm Corporation
- Agilent Technologies, Inc.
- Nanostring Technologies, Inc.
- Tecan Group Ltd.
- Sartorius AG
- Luminex Corporation
- Takara Bio Inc.
- Fluxion Biosciences
- Menarini Silicon Biosystems
For more information about this report visit https://www.researchandmarkets.com/r/ghrwyp